CCI4EU

CCI4EU - Comprehensive Cancer Infrastructures 4 Europe

CCI4EU is an ambitious European Union initiative that supports the goals of the Europe’s Beating Cancer Plan by strengthening national and regional Comprehensive Cancer Infrastructures (CCI), with the aim of promoting equitable access to cancer care, research, and innovation across Europe.
The objective of CCI4EU is to develop a coordinated, patient-cenetred, and sustainable cancer care infrastructure that integrates healthcare, research, training, and digitalization.

The project’s activities are based on a targeted situational assessment, in-depth country visits (Deep Dives), multidisciplinary working groups, and knowledge-transfer mechanisms. Special attention is given to countries with the greatest needs in the field of cancer in order to reduce disparities between Member States.

Project objectives:
• To map and analyze existing cancer infrastructures and capacities in the Member States;
• To promote the implementation and dissemination of comprehensive cancer care models;
• To develop training and knowledge-transfer mechanisms;
• To ensure close alignment between healthcare, research, public engagement, and policymakers;
• To develop recommendations for the sustainable implementation of CCIs across all EU Member States.

Project implementation period: 01.05.2023–30.04.2026

Project number: ID No. 101103746, UL reg. No. ZD2023/21497

Total project budget: EUR 9,984,080.25

UL total funding: EUR 53,375.00

Scientific lead: Dr. Ilze Eņģele

Coordinator: Organisation of European Cancer Institutes (OECI) – an international organisation with extensive experience in fostering collaboration among cancer centres and developing quality standards.

Consortium:
The project involves 55 partners from 27 EU Member States and 5 associated countries. The consortium includes universities, cancer centres, health ministries, patient organisations, research institutes, and international associations from across Europe. Among the partners are organisations such as OECI, IARC (WHO), ESMO, Istituto Nazionale Tumori (Italy), Charité Universitätsmedizin Berlin (Germany), Vall d'Hebron (Spain), the Ministry of Health of Slovenia, the Polish National Cancer Centre, the University of Tartu, and many others.